Thanasis headshot

Athanasios (Thanasis) Rempakos, MD

Center for Coronary Artery Disease International Scholar

Athanasios (Thanasis) Rempakos, MD joined the Center of Coronary Artery Disease as an International Research Scholar. In his role, Thanasis will work on various CCAD IIS projects, including REBIRTH, GE-OCT, NASA, PROGRESS-CTO, PROGRESS Bifurcations, PROGRESS Complications and others.

Dr. Rempakos comes to us from Athens, Greece where he obtained his MD from the National and Kapodistrian University of Athens in 2021. Following graduation from medical school, Thanasis worked as a Research Assistant at Alexandra General Hospital in Athens within the Heart Failure Outpatient clinic. He has also worked as a USMLE Tutor and as a Sports Event Physician in Greece.

Thanasis has a keen interest in medical research and particularly in cardiovascular disease. He enjoys helping others, both directly through clinical practice, but also indirectly through research, and finds it to be one of the most rewarding experiences and a driving force that helps him continuously strive to become better.

Back to Coronary Team Back to Current Scholars

Thanasis headshot
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.